Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Kelly

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Nature Structural Biology|March 31, 2000
Rational design of potent human transthyretin amyloid disease inhibitorsT Klabunde, H M Petrassi, V B Oza, et al.
Journal of the American Academy of Dermatology|January 1, 1994
Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildrenJ W Kelly, J K Rivers, R MacLennan, et al.
Annals of Surgery|December 1, 1984
The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanomaJ W Kelly, R W Sagebiel, W Calderon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Inhibiting transthyretin conformational changes that lead to amyloid fibril formationS A Peterson, T Klabunde, H A Lashuel, et al.
The British Journal of Dermatology|March 25, 2018
Impact of naevus association on survival for nodular and superficial spreading melanomasM Vu, N R Adler, E Wee, et al.
The British Journal of Dermatology|October 20, 2019
Acral lentiginous melanoma: differences in survival compared with other subtypesM D Howard, C Xie, E Wee, et al.
The EMBO Journal|November 15, 2001
Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilizationC D Chen, M E Huff, J Matteson, et al.
Science (New York, N.Y.)|January 13, 1989
Peptide and protein synthesis by segment synthesis-condensationE T Kaiser, H Mihara, G A Laforet, et al.
Journal of Neural Engineering|December 14, 2011
Toward smarter BCIs: extending BCIs through hybridization and intelligent controlB Z Allison, R Leeb, C Brunner, et al.
Biochemistry|September 19, 2001
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denaturedX Jiang, C S Smith, H M Petrassi, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Nature Structural Biology|March 31, 2000
Rational design of potent human transthyretin amyloid disease inhibitorsT Klabunde, H M Petrassi, V B Oza, et al.
Journal of the American Academy of Dermatology|January 1, 1994
Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildrenJ W Kelly, J K Rivers, R MacLennan, et al.
Annals of Surgery|December 1, 1984
The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanomaJ W Kelly, R W Sagebiel, W Calderon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Inhibiting transthyretin conformational changes that lead to amyloid fibril formationS A Peterson, T Klabunde, H A Lashuel, et al.
The British Journal of Dermatology|March 25, 2018
Impact of naevus association on survival for nodular and superficial spreading melanomasM Vu, N R Adler, E Wee, et al.
The British Journal of Dermatology|October 20, 2019
Acral lentiginous melanoma: differences in survival compared with other subtypesM D Howard, C Xie, E Wee, et al.
The EMBO Journal|November 15, 2001
Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilizationC D Chen, M E Huff, J Matteson, et al.
Science (New York, N.Y.)|January 13, 1989
Peptide and protein synthesis by segment synthesis-condensationE T Kaiser, H Mihara, G A Laforet, et al.
Journal of Neural Engineering|December 14, 2011
Toward smarter BCIs: extending BCIs through hybridization and intelligent controlB Z Allison, R Leeb, C Brunner, et al.
Biochemistry|September 19, 2001
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denaturedX Jiang, C S Smith, H M Petrassi, et al.
Pageof 13